This presentation explores the dynamic post-pandemic terrain of clinical translation in
biodegradable and bioactive materials research at the Korea Institute of Science and
Technology (KIST). By addressing challenges and seizing opportunities in this evolving field,
KIST aims to lead innovations crucial for shaping the future of healthcare.
In the wake of the pandemic, the significance of biodegradable and bioactive materials has
been magnified, given their critical role in areas such as tissue engineering, regenerative
medicine, and implantable medical devices. At KIST, researchers have been at the forefront,
leveraging innovative methodologies to engineer materials poised to meet the evolving
demands of healthcare.

Other speakers:
Dr. Hyeok Kim – ‘Nanovesicles Derived from Adipose-Derived Stem Cells Loaded with Prussian Blue for Ischemia-Reperfusion Injury’
Dr. Yuna Jung – ‘Harnessing Plant-Derived Nanovesicles for Diabetic Foot Ulcers: A Promising Approach to Chronic Wound Therapy’